Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Molecular Classification of Large B-Cell Non-Hodgkin LymphomaKamil Bojarczuk, Kirsty Wienand, Bjoern Chapuy
Biotechnology Journal|September 22, 2007
Yttrium 90 ibritumomab tiuxetan (Zevalin): a new bullet in the fight against malignant lymphoma?Bjoern Chapuy, Karin Hohloch, Lorenz Trümper
Plos One|October 11, 2019
LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cellsWenjiang Ma, Yan Qin, Bjoern Chapuy, et al.
Biochimica Et Biophysica Acta|September 10, 2014
MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implicationsTomasz Sewastianik, Monika Prochorec-Sobieszek, Bjoern Chapuy, et al.
Scientific Reports|November 16, 2019
Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysisAmy Li, Bjoern Chapuy, Xaralabos Varelas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2014
Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivoYansheng Hao, Bjoern Chapuy, Stefano Monti, et al.
Ejhaem|July 18, 2022
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupKarin Hohloch, Marita Ziepert, Lorenz Truemper, et al.
British Journal of Haematology|June 22, 2011
Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylationBjoern Chapuy, Nikolai Schuelper, Melanie Panse, et al.
Haematologica|July 5, 2006
CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cellsGerald G Wulf, Anita Boehnke, Bjoern Chapuy, et al.
Haematologica|November 3, 2009
ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drugBjoern Chapuy, Melanie Panse, Ulf Radunski, et al.
Pageof 7